Tickerplace logo

Tickerplace

Viking Therapeutics, Inc. logo

VKTXViking Therapeutics, Inc.

VKTX Stock Price, Valuation & Chart | Viking Therapeutics, Inc.

Compare
$32.160-1.70 (-5.02%)

At close · 28 Aug 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyVKTX intrinsic valueVKTX calculated fair value vs price
OverviewFinancialsDividendsRatios

VKTX Historical price chart

VKTX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization3.75B
PE Ratio-6.9
EPS-4.66
Trading Volume2.37M
Today's High/Low33.86/32.0
Dividend Yield0.00
52 Week High/Low43.15/22.96
Shares Outstanding116.65M
VKTX Financial Statement
VKTX Analyst ratings
VKTX Analysis & performance metrics

VKTX Company profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead…

VKTX Management team

Management
Michael Morneau
Vice President of Finance & Administration
Brian Lian Ph.D.CEO
President, Chief Executive Officer & Director
Gregory S. Zante CPA, CPACFO
Chief Financial Officer
Marianne ManciniCOO
Chief Operating Officer
Geoffrey E. Barker Ph.D.
Chief Development Officer
Total 5 executives

VKTX Frequently asked questions

What is Viking Therapeutics, Inc. (VKTX) Stock Price?

Current stock price of Viking Therapeutics, Inc. (VKTX) stock is $32.160. The stock price is -5.02% lower in the session. The intraday range can be seen from this page. Volume of Viking Therapeutics, Inc. (VKTX) stock is 2.37M.

Last updated at 28 Aug 2026, 08:00 pm.

Why is the Viking Therapeutics, Inc. (VKTX) stock price going up or down today?

The stock price of Viking Therapeutics, Inc. (VKTX) can change with earnings, company news, and overall market sentiment. Viking Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Viking Therapeutics, Inc. stock expensive at its current price?

Whether Viking Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VKTX on this page is -6.90. EPS on this page is -4.66. Compare those figures with peers and growth expectations before deciding if the current Viking Therapeutics, Inc. price is justified.

How has the stock price of Viking Therapeutics, Inc. (VKTX) performed historically?

Historical performance for Viking Therapeutics, Inc. (VKTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VKTX reacted to past earnings and market events.

Should I buy Viking Therapeutics, Inc. (VKTX) stock, at this price?

Buying Viking Therapeutics, Inc. (VKTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.